AA
Andrew Astor
President, CEO & CFODirector

Andrew Astor insider trades: Nephros (NEPH) stock purchases

President, CEO & CFO, Nephros Last trade Aug 18, 2021 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2017
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 18, 2021NEPH↑ Buy$39K
Nov 19, 2020NEPH↑ Buy$6K
Aug 19, 2020NEPH↑ Buy$7K
May 28, 2020NEPH↑ Buy$7K
Mar 12, 2020NEPH↑ Buy$7K
Mar 5, 2020NEPH↑ Buy$6K
Nov 18, 2019NEPH↑ Buy$6K
Aug 22, 2019NEPH↑ Buy$10K
Jun 14, 2019NEPH↑ Buy$22K
Apr 10, 2018NEPH↑ Buy$36K
Mar 9, 2018NEPH↑ Buy$2K
Dec 4, 2017NEPH↑ Buy$9K
Aug 28, 2017NEPH↑ Buy$3K
Aug 11, 2017NEPH↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andrew Astor's insider trades

Andrew Astor is President, CEO & CFO at Nephros (NEPH). Since Aug 11, 2017, Andrew has reported 14 open-market purchases worth $166K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), option exercises (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.